New preprint: predicting rifampicin resistance Philip Fowler, 16th August 202416th August 2024 In this preprint we train a series of machine learning models on protein mutations found in rpoB — this is the gene in the M. tuberculosis RNA polymerase complex where mutations can introduce resistance to rifampicin, an important first-line drug in the treatment of tuberculosis. Unlike pyrazinamide, which we have previously published and binds to pncA, the RNA polymerase is an essential gene and therefore resistance-conferring mutations tend to be subtle and, in this case, mostly close to the rifampicin binding site. We find that all the models achieve similar levels of prediction performance and that the most predictive feature is, perhaps unsurprisingly, the distance from the amino acid being mutated to the centre of mass of rifampicin. All the data and code required to create our Test+Train datasets, train the models and produce nearly all the figures in the preprint is available on GitHub. Share this:Twitter Related antimicrobial resistance computing publication research tuberculosis
antimicrobial resistance Accelerating Oxford Nanopore basecalling 26th January 20175th August 2018 It looks innocuous sitting on the desk, an Oxford Nanopore MinION, but it can produce… Share this:Twitter Read More
computing GROMACS on AWS 13th January 20164th December 2016 In this post I’m going to show how I created an Amazon Machine Instance with… Share this:Twitter Read More
antimicrobial resistance New paper: Infection Inspection 10th September 202410th September 2024 This paper is the cumulation of a lot of hard work by an interdisciplinary team… Share this:Twitter Read More